Roche Indonesia Supports Children with Cancer
This publication is authored by and reflected the views and opinion of PT Roche Indonesia. More information about PT Roche Indonesia is available on www.roche.co.id.
The 21st Roche Children’s Walk: Employees Raise Funds for Children with Cancer at Yayasan Kasih Anak Kanker Indonesia
Jakarta, 3 July 2024 – Roche Indonesia once again held its annual Roche Children's Walk, a fundraising event by Roche employees worldwide aimed at helping children in need both locally and globally. This year marks the 21st anniversary of the event. Through creative means such as bazaars, food sales, talent shows, running, and offering various services, Roche Indonesia employees successfully raised Rp 180,793,063. The funds were donated to children with cancer through Yayasan Kasih Anak Kanker Indonesia (YKAKI). The children supported by YKAKI come from low-income families and rely on financial assistance.
In a video message, Budi Gunadi Sadikin, the Minister of Health of the Republic of Indonesia, expressed his appreciation for the event. “May the donations for Yayasan Kasih Anak Kanker Indonesia greatly benefit the children under its care. I also hope that the dedication of all Roche Indonesia employees can inspire more parties to work together to realize the transformation of Indonesia’s health system,” he said. The Roche Children’s Walk is celebrated simultaneously in 75 countries and over 165 locations.
Funds raised by employees are matched by the company and used to support projects for children worldwide related to education, nutrition, primary healthcare, and social development. Globally, a total of CHF 23 million has been raised since the initiative began in 2003, collected by over 315,000 Roche employees.
"Roche is proud to continue this important annual tradition and continue benefiting children worldwide," said Lucia Erniawati, Access, Communication, and Healthcare System Value Strategy Director at Roche. "We believe that the tangible actions of all employees can impact the quality of life for children in need. Since 2015, our employees in Indonesia have raised donations amounting to more than 1.5 billion rupiah. Our continued support for this event aligns with our commitment to make a sustainable impact in the communities where we live and work."
Ira Soelistyo, Founder of Yayasan Kasih Anak Kanker Indonesia (YKAKI), added, "We are very grateful for the continuous support from Roche, who has supported us since the early days of YKAKI. The Roche Children’s Walk activities are always interesting, unique, and showcase the solidarity of all employees to make an impact on children in need."
With strong spirit and commitment, Roche continues to strive to make a positive impact on children worldwide and help create a better future for them.
###
About Roche
Roche is a pioneer in the pharmaceutical and diagnostics industry worldwide, focusing on advancing science to improve patients’ lives. The combination of pharmaceutical and diagnostics strengths under one roof has made Roche one of the leaders in personalized healthcare – a strategy aimed at providing the right treatment solution for each patient. Roche is the world's largest biotech company, with cutting-edge treatments in oncology, immunology, infectious diseases, eye diseases, and central nervous system disorders. Roche is also the leading company for in-vitro diagnostics, tissue-based cancer diagnostics, and a pioneer in diabetes management.
Founded in 1896, Roche continuously seeks better ways to prevent, diagnose, and treat diseases, contributing sustainably to global health. More than 30 medicines developed by Roche are included in the World Health Organization’s Model List of Essential Medicines, including antibiotics, antimalarials, and cancer medicines. For eleven consecutive years, Roche has been recognized as one of the most sustainable companies in the Pharmaceutical Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, operates in over 100 countries and in 2019 employed more than 98,000 people worldwide. In 2019, Roche invested over CHF 11.7 billion in R&D and achieved sales of CHF 61.5 billion. Genentech, in the United States, is wholly owned by the Roche Group. Roche is also the majority shareholder in Chugai, Japan.
For more information, visit www.roche.com | www.roche.co.id.
About YKAKI
Founded in 1994, Yayasan Kasih Anak Kanker Indonesia (YKAKI) is one of two organizations exclusively dedicated to advocating for and supporting children with cancer. Since its inception, YKAKI has supported thousands of children affected by cancer by providing housing, education, transportation, and ensuring children undergoing treatment continue their therapy. YKAKI also continuously raises public awareness about childhood cancer issues.
For more information, please contact:
Audina Sheila Larassati
Corporate Communications Value Partner
audina_sheila.larassati@roche.com
--
This publication is authored by and reflected the views and opinion of PT Roche Indonesia. More information about PT Roche Indonesia is available on www.roche.co.id.